Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 1 1

Status

Terminated 2Recruiting 1

Sponsor Class

INDUSTRY 6OTHER 5NETWORK 3NIH 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 3

Conditions

Breast Neoplasms 90Prostatic Neoplasms 55Lymphoma 34Leukemia 32Carcinoma, Non-Small-Cell Lung 31Multiple Myeloma 30Head and Neck Neoplasms 30Colorectal Neoplasms 29Squamous Cell Carcinoma of Head and Neck 28Lung Neoplasms 27Precursor Cell Lymphoblastic Leukemia-Lymphoma 25Colonic Neoplasms 24Leukemia, Myeloid, Acute 22Rectal Neoplasms 21Neoplasm Metastasis 20Sarcoma 19Ovarian Neoplasms 19Central Nervous System Neoplasms 18Uterine Cervical Neoplasms 17Hodgkin Disease 17Burkitt Lymphoma 15Brain Neoplasms 15Carcinoma, Ovarian Epithelial 14Pain 12Lymphoma, Follicular 12Urinary Bladder Neoplasms 11Lymphoma, Large B-Cell, Diffuse 11Fallopian Tube Neoplasms 11Endometrial Neoplasms 11Astrocytoma 11

Interventions

tebentafusp 1fotemustine 1MART-1 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × NETWORK × Uveal Melanoma × Clear all
NCT06246149 2026-03-04

ATOM

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Recruiting
290 enrolled
Dermatologic

Uveal Melanoma

NCT00036816 2012-09-24

Vaccine Therapy in Treating Patients With Melanoma of the Eye

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Terminated
13 enrolled
Dermatologic

Uveal Melanoma

NCT00110123 2012-09-24

Intravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients With Unresectable Liver Metastases From Eye Melanoma

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Terminated
171 enrolled
Dermatologic

Uveal Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡